Stock INBX INHIBRX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Inhibrx, Inc.

Equities

INBX

US45720L1070

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
34.09 USD -0.84% Intraday chart for Inhibrx, Inc. -1.04% -10.29%
Feb. 28 Inhibrx Shares Fall After Q4 Net Loss Widens MT
Feb. 28 Earnings Flash (INBX) INHIBRX Reports Q4 Revenue $1.6M MT

Evolution of the average Target Price on Inhibrx, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e.4LLXRZe-ipNfm7AFGfPq4_aEYBwen0npBaHeWD08FS8.kciCdOLOuvBq9sZwWr-_tbD2MG16-hmHb9mbIQ5TcG7RgqMdx9_l4RvB5Q~bee761da05e252f5646722c17ce7ffb4

Analyst Recommendations on Inhibrx, Inc.

JMP Securities Downgrades Inhibrx to Market Perform From Market Outperform MT
JMP Securities Adjusts Inhibrx Price Target to $27 From $35, Maintains Market Outperform Rating MT
JMP Securities Adjusts Price Target on Inhibrx to $35 From $40, Maintains Market Outperform Rating MT
Credit Suisse Lowers Inhibrx's Price Target to $46 From $48, Keeps Outperform Rating MT
Evercore ISI Raises Inhibrx's Price Target to $60 From $54, Maintains Outperform Rating MT
Credit Suisse Lowers Inhibrx's Price Target to $48 from $53, Updates Model to Reflect Q2 Actuals; Keeps Outperform Rating MT
SMBC Nikko Starts Inhibrx at Outperform With $40 Price Target MT
JMP Securities Adjusts Inhibrx Price Target to $40 From $53, Maintains Market Outperform Rating MT
Credit Suisse Raises Inhibrx's PT to $53 from $44 After Chat with CEO, Notes Higher-than-Consensus Q3 Revenue; Keeps Outperform Rating MT
JMP Securities Adjusts Price Target on Inhibrx to $53 From $46, Maintains Market Outperform Rating MT
INHIBRX : JMP Securities Starts Inhibrx at Market Outperform with $46 Price Target MT
INHIBRX : Credit Suisse Adjusts Inhibrx' Price Target to $44 from$28, Keeps Outperform Rating MT
INHIBRX : Jefferies Adjusts Inhibrx PT to $50 From $30, Maintains Buy Rating MT
INHIBRX : Credit Suisse Adjusts Inhibrx' Price Target to $28 from $26, Keeps Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
34.09 USD
Average target price
35.5 USD
Spread / Average Target
+4.14%
High Price Target
36 USD
Spread / Highest target
+5.60%
Low Price Target
35 USD
Spread / Lowest Target
+2.67%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Inhibrx, Inc.

JMP Securities
Credit Suisse
Evercore ISI
SMBC Nikko

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. INBX Stock
  4. Consensus Inhibrx, Inc.